SPHINX is a selective SRPK1 inhibitor with an IC50 value of 0.58 µM. SPHINX effectively reduces Choroidal Neovascularization (CNV) in vivo. SPHINX can be used for the research of (age-related macular degenaration) AMD[1].
Molecular Weight:
354.32
Purity:
99.87
CAS Number:
[848057-98-7]
Formula:
C17H17F3N2O3
Target:
SRPK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted